Last reviewed · How we verify
Complicated Bacterial Peritonitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Tygacil · Fresenius Kabi
Tygacil works by binding to the 30S ribosomal subunit of bacteria, preventing the aminoacyl-tRNA from binding and thereby inhibiting protein synthesis. - Ciprofloxacine · Poitiers University Hospital
- Gentamicin · Merck & Co.
- Tygacil · Pfizer
Tigecycline is a tetracycline class antibacterial agent. - Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Noroxin
- Floxin
- Cipro · Bayer AG
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated Bacterial Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Complicated Bacterial Peritonitis treatment landscape brief
- Complicated Bacterial Peritonitis treatment updates RSS
Frequently asked questions about Complicated Bacterial Peritonitis
What drugs treat Complicated Bacterial Peritonitis?
Tracked treatments include Ramycin, Garamycin, Tygacil, Ciprofloxacine, Gentamicin, Invanz, Arikayce Kit, Noroxin.
What is the treatment for Complicated Bacterial Peritonitis?
Standard treatment for Complicated Bacterial Peritonitis includes Ramycin, Garamycin, Tygacil, Ciprofloxacine, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated Bacterial Peritonitis patent cliff · Complicated Bacterial Peritonitis CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Tygacil · Fresenius Kabi
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing